Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
41 Leser
Artikel bewerten:
(0)

Aditazz expands its global reach with a Cancer Research Hospital win for the Li Ka Shing foundation

SAN BRUNO, Calif., Oct. 31, 2013 /PRNewswire/ --Aditazz announced its international expansion by winning the landmark Cancer Research Hospital project at Shantou University, China, sponsored by the Li Ka Shing Foundation (LKSF), a premier charitable institution with education and healthcare as its primary focus.

The stark reality of a high incident rate of cancer confronts China-- six patients are diagnosed with cancer every minute according to the 2012 China Cancer Census. As China grapples with the crisis, it has adopted an aggressive approach and is opening treatment facilities nationwide. There is however a growing need for cancer research focused on prevention, early detection and treatment specific to the local conditions.

"The Aditazz services and technology promise to be a more efficient and cost effective way to extend our charitable resources to solving the basic need of improved health" said Dr. Frieda Law, speaking on behalf of LKSF. "We are eager to apply Silicon Valley innovation and technology to creating healthcare infrastructure that paves the path to a quantum improvement in the quality of patient care while minimizing capital and operating costs."

Continuing its momentum and commitment to integrate innovations in design, technology and manufacturing while solving complex infrastructure problems, Aditazz is uniquely positioned to address the staggering challenges of healthcare construction in China. Elaborating on the significance of the project, Deepak Aatresh, Aditazz co-founder said, "This win gives Aditazz yet another opportunity to apply its one-of-a-kind patented solution to a problem of enormous magnitude. Healthcare is a global challenge. We are delighted to be selected due to our unique ability to bring scalable technology and services to address this challenge of global scale."

Shantou University Medical College Cancer Hospital professor, Dr. Guo-Jun Zhang, highlighted the Silicon Valley allure: "We are excited to launch the project with the much needed multi-disciplinary collaboration between design, construction, and healthcare experts from around the globe; all stitched together with the innovative Aditazz approach. This is the first time we are seeing an approach that is rooted in technology from Silicon Valley and is an appropriate response to the staggering challenges of cancer diagnosis and treatment faced by our community."

About Aditazz

Aditazz designs and delivers next-generation complex buildings by integrating innovations in design, technology and manufacturing. Based in Silicon Valley, the company brings together experts and innovations from the worlds of semiconductor design, computer science, architecture, systems and structural engineering, modular manufacturing and assembly, and planning and operations. It has created a new generation of tools and technologies that results in dramatic increases in building construction speed, flexibility, predictability and cost-savings- all while maintaining the highest degree of aesthetic and functional performance. Aditazz received funding from Artiman Ventures (www.artiman.com) and is a co-winner of Kaiser Permanente's 2012 'Small Hospital, Big Idea' design competition. For more information, please visit www.aditazz.com.

About Li Ka Shing Foundation

The Li Ka Shing Foundation was created in 1980 to coordinate and provide philanthropic contributions towards medical, educational, cultural and other community welfare projects with a focus on Hong Kong and Mainland China. The Li Ka Shing Foundation has supported numerous charitable activities with grants, sponsorships and commitments in excess of $1 Billion.

About Shantou University Cancer Hospital

Shantou University Cancer Hospital is part of the Medical School at Shantou University, a public university in Shantou, China that receives funding from the Li Ka Shing Foundation. The University was formed in 1981 and consists of 9 schools and colleges.

SOURCE Aditazz

© 2013 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.